IPO Calendar
Lead Manager
- J P Morgan Chase (490)
- Goldman Sachs (463)
- Morgan Stanley (421)
- Bank of America Merrill Lynch (358)
- Citigroup (222)
- Jefferies (214)
- Credit Suisse (180)
- Barclays (151)
- Cowen and Company (147)
- Deutsche Bank (84)
- Leerink Partners (70)
- Piper Jaffray (70)
- Stifel (65)
- UBS Investment Bank (53)
- Evercore (52)
- RBC Capital (51)
- BMO Capital (49)
- Wells Fargo (47)
- Raymond James (38)
- William Blair (37)
More +
IPO - Pricing (9)
Piper Jaffray
UnderWriters* | |||||||||||
Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 14 | Bellicum Pharma | Health-Care | 19 | 7 | CITI | JEFF | PPRJ | 129.4% | 25.7% | ||
Sep 27 | Ra Medical Syst | Health-Care | 17 | 3 | CNTR | PPRJ | 60.6% | 17.6% | |||
Sep 27 | Sutro Biopharma | Health-Care | 15 | 5 | COWN | PPRJ | 47.7% | 1.3% | |||
Sep 27 | Arvinas Inc. | Health-Care | 16 | 7 | CITI | GS | PPRJ | 45.6% | 0.3% | ||
Jul 18 | Crinetics Pharm | Health-Care | 17 | 6 | JPM | LRNK | PPRJ | 60% | 44.2% | ||
Jun 28 | Neuronetics Inc | Health-Care | 17 | 5 | PPRJ | WB | 45.5% | 63.4% | |||
Jun 22 | electroCore Inc | Health-Care | 15 | 5 | EVCR | JMPS | PPRJ | 35.2% | 32.3% | ||
May 4 | ASLAN Pharmaceu | Health-Care | 7 | 6 | LRNK | PPRJ | 13.6% | -20.2% | |||
Feb 14 | Motus GI Holdin | Health-Care | 5 | 3 | OPPN | PPRJ | 18.6% | -12.4% |
*
Lead manager or one of top three managers in an underwriting team.